Related Experiment Video
Updated: Nov 10, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Pathology of COVID-19-associated acute kidney injury
Purva Sharma1,2, Jia H Ng1, Vanesa Bijol2,3
1Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, New Hyde Park, NY, USA.
Insights
Acute kidney injury (AKI) is a frequent complication in COVID-19 patients. This review details kidney pathologies, with acute tubular injury being most common, aiding in AKI management and patient survival.
Area of Science:
- Nephrology
- Infectious Diseases
- Pathology
Background:
- Acute kidney injury (AKI) is a significant complication in hospitalized coronavirus disease 2019 (COVID-19) patients.
- The incidence of AKI in COVID-19 cases varies widely, ranging from 0.5% to 80%.
- Understanding the kidney pathology in COVID-19 is essential for effective AKI management and improving patient outcomes.
Purpose of the Study:
- To review and summarize the diverse kidney pathologies observed in patients with COVID-19.
- To consolidate findings from published case reports and series on COVID-19-associated kidney injury.
- To provide insights into the pathological mechanisms underlying AKI in the context of COVID-19.
Main Methods:
- Systematic review of published literature on kidney pathologies in COVID-19 patients.
- Analysis of data from live kidney biopsies and autopsy findings.
- Compilation of reported cases and case series detailing renal manifestations of COVID-19.
Main Results:
- Acute tubular injury is the most frequently identified kidney pathology in COVID-19 patients.
- Collapsing glomerulopathy and thrombotic microangiopathy are also observed in kidney tissues.
- Less common findings include anti-neutrophil cytoplasmic antibody vasculitis, anti-glomerular basement membrane disease, and podocytopathies.
- Direct viral infection of the kidney was not a common finding in the reviewed literature.
Conclusions:
- COVID-19 is associated with a spectrum of kidney pathologies, predominantly acute tubular injury.
- While direct viral invasion may occur, other mechanisms likely contribute significantly to AKI in COVID-19.
- Further research into the pathogenesis of COVID-19-related kidney disease is warranted to guide clinical practice.
Abstract:
Acute kidney injury (AKI) is common among hospitalized patients with coronavirus disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. An improved knowledge of the pathology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who develop AKI during COVID-19. In this review, we summarize the published cases and case series of various kidney pathologies seen with COVID-19. Both live kidney biopsies and autopsy series suggest acute tubular injury as the most commonly encountered pathology. Collapsing glomerulopathy and thrombotic microangiopathy are other encountered pathologies noted in both live and autopsy tissues. Other rare findings such as anti-neutrophil cytoplasmic antibody vasculitis, anti-glomerular basement membrane disease and podocytopathies have been reported. Although direct viral infection of the kidney is possible, it is certainly not a common or even widespread finding reported at the time of this writing (November 2020).
More Related Videos
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Pyelonephritis I: Introduction

